Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000299250 encodes a long non-coding RNA (lncRNA), described as a "novel transcript, antisense to KIAA0408 and ECHDC1." It is transcribed from the opposite strand relative to the nearby protein-coding genes KIAA0408 and ECHDC1 on chromosome 6. No protein product, biological function, disease association, or drug interactions have been reported for this transcript. It does not qualify as a direct therapeutic target such as a receptor, enzyme, or transporter[9][1][5]. The designation "antisense" indicates that this lncRNA is transcribed in the opposite direction to KIAA0408 and ECHDC1, but its regulatory or biological impact is uncharacterized. While ECHDC1 and KIAA0408 are protein-coding genes with known or suspected cellular functions, ENSG00000299250 is itself a non-coding RNA and not a standard druggable target[9][1][7]. This entry is most accurately classified as a non-coding RNA gene with unknown function rather than a receptor, enzyme, or therapeutic target.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to KIAA0408 and ECHDC1 (ENSG00000299250).